Medical blog can invade patient privacy
HIPAA rules expect the utmost in patient privacy, even online.
Medical blogs may threaten patient privacy, according to a new study published online in the Journal of General Internal Medicine. The Robert Wood Johnson Foundation and researchers at the University of Pennsylvania examined content from 271 medical blogs and found that more than half contained enough information to reveal the author’s identity.
Although researchers say that overt violations of patient privacy are rare, “anonymous” medical bloggers who provide information about their location, subspecialty or other personal details inadvertently reveal their identity to patients, colleagues or other members of the public. In some cases, patients described in these blogs may be able to identify themselves.
MHE Editorial Advisor Joel V. Brill, MD, chief medical officer of Predictive Health LLC believes that managed care executives can help by developing a policy to address appropriate corporate policies regarding official and unofficial posts.
“Companies may wish to monitor what is being said about you and what your employees are blogging about,” Dr. Brill says. “Although this [research] addresses privacy issues by physicians, it is just as important from a corporate perspective, especially if your employees are inadvertently providing information. Once it’s out on the Internet, it’s accessible to all.”
Researchers Develop a New Way to Deliver Gene Therapies to the Brain
May 23rd 2025Scientists working at the NIH’s BRAIN Initiative have created new viral vectors that one day could lead to gene therapies for ALS, seizure disorders, Parkinson’s and Alzheimer’s disease, Huntington’s disease and other diseases of the brain.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Gene Therapy Elevidys Slows Motor Decline In Boys With Duchenne, Phase 3 Trial Shows
May 22nd 2025Developed by Sarepta Therapeutics, Elevidys is a one-time, intravenous treatment that uses adeno-associated virus (AAV) technology to deliver a gene designed to produce a shortened form of the dystrophin protein, known as Elevidys micro-dystrophin, directly to skeletal muscle.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Careful Consideration Needed for Management of Acquired (Autoimmune) Hemophilia
May 22nd 2025Patients diagnosed with acquired (autoimmune) hemophilia, a serious and rare bleeding disorder, have high rates of hospital readmissions because of infections and bleeding, as well as high death rates especially among older patients.
Read More
